Amica Retiree Medical Trust lowered its holdings in shares of Accenture plc (NYSE:ACN – Free Report) by 8.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,666 shares of the information technology services provider’s stock after selling 232 shares during the period. Accenture makes up about 0.9% of Amica Retiree Medical Trust’s holdings, making the stock its 27th biggest position. Amica Retiree Medical Trust’s holdings in Accenture were worth $938,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in ACN. Morse Asset Management Inc bought a new stake in shares of Accenture in the 3rd quarter valued at $25,000. FPC Investment Advisory Inc. increased its stake in Accenture by 62.2% in the fourth quarter. FPC Investment Advisory Inc. now owns 73 shares of the information technology services provider’s stock valued at $28,000 after purchasing an additional 28 shares in the last quarter. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Accenture during the fourth quarter valued at about $30,000. POM Investment Strategies LLC grew its stake in shares of Accenture by 64.2% in the 4th quarter. POM Investment Strategies LLC now owns 87 shares of the information technology services provider’s stock valued at $31,000 after buying an additional 34 shares during the period. Finally, Retirement Wealth Solutions LLC bought a new stake in Accenture in the 4th quarter valued at about $34,000. 75.14% of the stock is owned by institutional investors and hedge funds.
Accenture Stock Performance
Shares of ACN opened at $311.38 on Thursday. Accenture plc has a 1 year low of $278.69 and a 1 year high of $398.35. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.47 and a quick ratio of 1.47. The stock’s fifty day moving average price is $356.77 and its two-hundred day moving average price is $356.56. The firm has a market cap of $194.86 billion, a PE ratio of 26.12, a PEG ratio of 3.23 and a beta of 1.24.
Accenture Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 10th will be given a $1.48 dividend. This represents a $5.92 annualized dividend and a dividend yield of 1.90%. The ex-dividend date is Thursday, April 10th. Accenture’s dividend payout ratio (DPR) is presently 48.89%.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. BMO Capital Markets raised their price objective on Accenture to $355.00 and gave the company a “hold” rating in a research note on Wednesday. JPMorgan Chase & Co. boosted their price target on shares of Accenture from $370.00 to $396.00 and gave the company an “overweight” rating in a research note on Monday, December 16th. StockNews.com lowered shares of Accenture from a “buy” rating to a “hold” rating in a research note on Tuesday, March 11th. Piper Sandler lowered their target price on shares of Accenture from $396.00 to $364.00 and set an “overweight” rating on the stock in a report on Thursday, March 20th. Finally, Mizuho cut their price target on Accenture from $428.00 to $398.00 and set an “outperform” rating for the company in a research note on Wednesday, March 19th. Eight equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Accenture currently has an average rating of “Moderate Buy” and a consensus price target of $378.23.
Read Our Latest Stock Analysis on ACN
Insider Activity at Accenture
In other Accenture news, CEO Julie Spellman Sweet sold 8,793 shares of the stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $394.47, for a total value of $3,468,574.71. Following the sale, the chief executive officer now directly owns 11,858 shares in the company, valued at $4,677,625.26. This represents a 42.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Melissa A. Burgum sold 1,487 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $354.54, for a total transaction of $527,200.98. Following the transaction, the chief accounting officer now owns 9,247 shares of the company’s stock, valued at $3,278,431.38. This trade represents a 13.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,905 shares of company stock worth $8,181,753. 0.02% of the stock is owned by company insiders.
Accenture Company Profile
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
Featured Articles
- Five stocks we like better than Accenture
- The Significance of Brokerage Rankings in Stock Selection
- Energy Transfer: Powering Data With Dividends and Diversification
- Insider Buying Explained: What Investors Need to Know
- Qualcomm Stock Is Coiling for a Breakout
- 3 Healthcare Dividend Stocks to Buy
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture plc (NYSE:ACN – Free Report).
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.